| 注册
首页|期刊导航|基础医学与临床|诱导肝星状细胞铁死亡治疗肝纤维化的研究进展

诱导肝星状细胞铁死亡治疗肝纤维化的研究进展

孙立杰 郝丹丹

基础医学与临床2024,Vol.44Issue(1):108-113,6.
基础医学与临床2024,Vol.44Issue(1):108-113,6.DOI:10.16352/j.issn.1001-6325.2024.01.0108

诱导肝星状细胞铁死亡治疗肝纤维化的研究进展

Progress of researches on inducing hepatic stellate cell ferroptosis for treatment of liver fibrosis

孙立杰 1郝丹丹2

作者信息

  • 1. 赤峰学院附属医院 普外科, 内蒙古 赤峰 024005
  • 2. 赤峰学院 基础医学院 生理学教研室, 内蒙古 赤峰 024000
  • 折叠

摘要

Abstract

Emerging evidence suggests that ferroptosis,an iron-dependent form of regulated cell death,plays a criti-cal role in the genesis of liver fibrosis through inducing hepatic stellate cell(HSC)ferroptosis to inhibit liver fibrosis or inducing hepatic ferroptosis to potentiates liver fibrosis.Pharmacologically targeting at ferroptosis with its inducers can slow down the progression of liver fibrosis in vitro and in vivo model.This review suggests that pharmacological in-duction of HSC ferroptosis might be used as a potential novel targeted therapy for the treatment of liver fibrosis.

关键词

肝纤维化/肝星状细胞/铁死亡

Key words

liver fibrosis/hepatic stellate cell/ferroptosis

分类

医药卫生

引用本文复制引用

孙立杰,郝丹丹..诱导肝星状细胞铁死亡治疗肝纤维化的研究进展[J].基础医学与临床,2024,44(1):108-113,6.

基金项目

内蒙古自然科学基金(2022MS08032) (2022MS08032)

基础医学与临床

OACSTPCD

1001-6325

访问量0
|
下载量0
段落导航相关论文